Sign in

Lost your password?
(close)

GLOBAL

Aducanumab Approval / Opening the Floodgates for a New Era of Alzheimer’s Treatment?

With the US FDA’s controversial recent decision to approve Biogen and Eisai’s aducanumab – the first approval for a new Alzheimer’s disease (AD) drug since 2003 – PharmaBoardroom has raided…

Global / Five Ways That AI Can Transform Pharma Market Access

Merck VP for Global Market Access & Pricing Strategic Planning Marco Rauland outlines how AI has already begun…

Vaccines / Industry Warns of Manufacturing Bottlenecks; Specific Data Still Lacking

Big Pharma’s representatives are warning of upcoming bottlenecks in the COVID-19 vaccine manufacturing supply…

Opinion / IP PACT: A Journey, Not a Destination

The issue of COVID-19 vaccine access in developing nations has thrust intellectual property (IP) into global…

In Conversation

João de Bragança & Nicole Scobie, Childhood Cancer International

Cancer is one of the most frightening words in any language but is especially heart-wrenching when it comes to children. João de Bragança, President of Childhood Cancer International (CCI) and Nicole Scobie, President of Zoé4life and CCI European Board Member, share CCI’s aims as the largest parent-led international organisation supporting children with cancer. de Bragança and Scobie also explain why…

João de Bragança & Nicole Scobie, Childhood Cancer…

João de Bragança & Nicole Scobie, Childhood Cancer…

João de Bragança & Nicole Scobie, Childhood Cancer International

Cancer is one of the most frightening words in any language but is especially heart-wrenching when it comes to…

Moderna / Bullish Bancel “Not Losing Sleep” over COVID-19 Vaccine IP Waiver, Looking to mRNA’s Future in Rare Diseases & Oncology

The day the Biden administration announced its support for the waiver of IP rights for COVID-19 vaccines,…

Pharma Logistics Under COVID / Partnerships, Digitalisation & New Customer Service Models

The vital importance of robust supply chains and distribution networks has been foregrounded over the past year as…

Novavax / From No-Hoper to COVID-19 Vaccine Saviour?

From almost being de-listed by the NASDAQ stock index in 2018 due to poor financial performance, US vaccine firm…

The COVID-19 Vaccine Rush / Nationalism, Access & IP Issues

The global rush to secure access to COVID-19 vaccines has led to accusations that richer countries are hoarding…

Global / Top 5 CDMOs

As the global pharmaceutical industry continues to grow, so have opportunities for service providers. Over the last…

Vaccines / IFPMA's Thomas Cueni on why "#TeamVaccines is all of us"

Thomas Cueni of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) highlights…

We use cookies to ensure that we give you the best experience on our site. For more info click here